Cyclophosphamide

cytochrome P450 family 27 subfamily A member 1 ; Homo sapiens







95 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 18396625 [Clinical analysis of late-onset nephrotic syndrome after allogenic hematopoietic stem cell transplantation]. 2007 Dec 11 1
52 16797508 Cyclophosphamide suppresses thioredoxin reductase in bladder tissue and its adaptive response via inductions of thioredoxin reductase and glutathione peroxidase. 2006 Jul 25 1
53 16978400 Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer. 2006 Sep 15 1
54 16995867 Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus. 2006 Oct 1
55 17217824 [Effect of adenovirus-mediated mutant exogenous P27kip1 gene expression on the chemosensitivities of cholangiocarcinoma cell line]. 2006 Oct 1 1
56 17343335 Synergistic interaction between a novel mixed ligand copper(II) chelate complex and a panel of anticancer agents in T47D human breast cancer cells in vitro. 2005 Apr-Jun 1
57 15645351 Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta. 2004 Dec 1
58 12586609 High-dose cyclophosphamide in multiple sclerosis patients undergoing autologous stem cell transplantation. 2003 Feb 1
59 12839696 [Oral combination chemotherapy of 5'-deoxy-5-fluorouridine (furtulon) and cyclophosphamide for advanced breast cancer]. 2003 May 1
60 12853690 Intermediate-dose cyclophosphamide and granulocyte colony-stimulating factor is a valid alternative to high-dose cyclophosphamide for mobilizing peripheral blood CD34+ cells in patients with multiple myeloma. 2003 2
61 14586142 Ifosfamide and cyclophosphamide: effects on immunosurveillance. 2003 1
62 14693069 [Clinical adjuvant chemotherapy base on chemosensitivity in nude mouse subrenal capsule assay for non-small cell lung cancer]. 2003 Dec 1
63 11810040 A phase I-II study on a gemcitabine-cyclophosphamide-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients. 2002 1
64 11863115 Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. 2002 Jan 1
65 12196358 Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide. 2002 Sep 1
66 11510034 Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: a Southern Italy Cooperative Oncology Group phase I/II study. 2001 Jun 1
67 11511721 Combination of cyclophosphamide and interferon-beta halts progression in patients with rapidly transitional multiple sclerosis. 2001 Sep 1
68 11787527 Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance. 2001 1
69 11776651 [Clinical observation of palitaxel in the treatment of gynecologic malignant tumors]. 2000 Mar 1
70 10496187 Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis. 1999 Sep 1 1
71 9336363 High-dose cyclophosphamide for poor-prognosis and recurrent pediatric brain tumors: a dose-escalation study. 1997 Oct 1
72 9377855 Phase I-II study of dose intensified chemotherapy with filgrastim and thymopentin in patients with advanced cancer. 1997 May-Jun 1
73 9416813 Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy. 1997 Dec 2
74 9594342 Effects of methylprednisolone and cyclophosphamide pulse therapy on renal infiltrating cells in patients with crescentic glomerulonephritis. 1997 Mar 1
75 8636747 High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. 1996 Feb 1
76 8940753 Repair capacity of mouse lung after total body irradiation alone or combined with cyclophosphamide. 1996 Sep 1
77 9816036 Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma. 1995 Jul 1
78 7985935 Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group. 1994 1
79 1423178 Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer. A Hoosier Oncology Group study. 1992 Nov 15 1
80 1919629 Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot study. 1991 Oct 1
81 2106164 Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination. 1990 Feb 1
82 2136026 The effect of "activated" cyclophosphamide on human and rat ovarian granulosa cells in vitro. 1990 2
83 2161174 Cisplatin and cyclophosphamide in advanced ovarian carcinoma: activity and toxicity of an ambulatory regimen. 1990 Jun 1
84 2191233 Treatment of rapidly progressive glomerulonephritis due to Behçet's syndrome with intravenous cyclophosphamide. 1990 1
85 2367754 The uptake and metabolism of cyclophosphamide by the ovary. 1990 Summer 2
86 2513138 The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo. 1989 1
87 3744939 Inhibition of the protective effect of cyclophosphamide by pre-treatment with buthionine sulfoximine. 1986 Jul 1
88 4038650 Polychemotherapy with carmustine, cyclophosphamide plus adriamycin in the treatment of advanced ovarian cancer. 1985 1
89 6713344 Treatment of diffuse poorly differentiated lymphocytic lymphoma. An analysis of prognostic variables. 1984 Jun 1 1
90 7066863 Treatment of advanced diffuse histiocytic lymphoma: an analysis of prognostic variables. 1982 Apr 15 1
91 6271847 Initial observations on the effects of delta 9-tetrahydrocannabinol on the plasma pharmacokinetics of cyclophosphamide and doxorubicin. 1981 Aug-Sep 1
92 7015645 A new CMF regimen. 1980 Dec 31 1
93 7459899 High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial. 1980 Oct-Nov 1
94 403484 [Treatment of advanced breast cancer with alkylating agents]. 1977 Mar 17 5
95 1232533 The effect of short-term cyclophosphamide on estrogen therapy in metastatic breast cancer. 1975 1